Trends in the Prevalence of Chronic Medication Use Among Children in Israel Between 2010 and 2019: Protocol for a

Yair Sadaka1,2, Dana Horwitz1, Leor Wolff3

  • 1Neuro-Developmental Research Centre, Beer Sheva Mental Health Centre, Ministry of Health, Beer Sheva, Israel.

Insights

This study analyzes trends in psychobehavioral and non-psychobehavioral medication use in children, identifying risk factors for chronic treatment. Findings aim to improve pediatric prescription policies and chronic care management.

Area of Science:

  • Pediatric pharmacology
  • Health services research
  • Biostatistics

Background:

  • Global increase in psychostimulant prescriptions for children.
  • Need to understand chronic medication use trends across pediatric age groups and sociodemographic factors.
  • Importance of differentiating therapy areas for cost and service evaluation.

Purpose of the Study:

  • Analyze trends in psychobehavioral vs. non-psychobehavioral medication prescriptions in children.
  • Identify risk factors and predictors for chronic medication use in pediatric populations.

Main Methods:

  • Retrospective study using Clalit Health Services data (2010-2019, ~1.5 million children aged 0-18).
  • Anatomical Therapeutic Chemical (ATC) codes for medication identification.
  • Time-trend analysis comparing psychobehavioral and non-psychobehavioral medication prescription trends.
  • Logistic regression and machine learning to identify risk variables and predict chronic treatment.

Main Results:

  • Data analysis is ongoing; results submission expected in 2022.
  • Study aims to elucidate trends in pediatric psychobehavioral and non-psychobehavioral medication use.
  • Expected to identify key risk factors and predictors for chronic medication use in children.

Conclusions:

  • Analysis of patient population response over time can inform prescription and follow-up policies.
  • Potential to improve management of chronic treatments for children.
  • Aims to enhance decision-making for healthcare providers and policymakers regarding pediatric medication.
Abstract

Related Concept Videos

Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.2K
Prescription, Nonprescription and Orphan Drugs01:02

Prescription, Nonprescription and Orphan Drugs

Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
842
Observational Studies01:11

Observational Studies

Observational studies are a type of analytical study where researchers observe events without any interventions. In other words, the researcher does not influence the response variable or the experiment's outcome.
There are three types of observational studies – Prospective, retrospective, and cross-sectional.
Prospective Study
Prospective studies, also known as longitudinal or cohort studies, are carried out by collecting future data from groups sharing similar characteristics. One...
8.9K
Longitudinal Studies01:26

Longitudinal Studies

Longitudinal studies are also widely used in other medical and social science fields. For instance, in cardiovascular research, they can monitor patients' health over decades to identify risk factors for heart disease, such as high cholesterol or smoking, and evaluate the long-term effectiveness of preventive measures. Similarly, in mental health studies, researchers might follow individuals from adolescence into adulthood to understand the development and progression of conditions like...
228
Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
974
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
374